A Study to Assess the Safety and Tolerability of Single Ascending Doses of REGN1033(SAR391786)

Clinical trial NCT01507402 · COMPLETED

Trial details

NCT number: NCT01507402
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2012-01-01
Primary completion: 2012-11-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.